Active Implants Corp
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Mar 2011 | $8 M | No. 2 | $2 to $10 million | debt, options | SEC | |
| Mar 2009 | $15 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Active Implants Corp had revenue of up to $1 million when it filed its newest notice of a funding round (May 2012).
SEC Form D (revenue range) · May 2012
Revenue range over time, as stated in its notices: revenue between $1 million and $5 million in 2009; revenue of up to $1 million in 2012.
SEC Form D (revenue range) · May 2012
The industry group it chose in its notices: Other Health Care.
SEC Form D · May 2012
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Active Implants Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 53 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Henry Klyce | Executive officer | May 2012 |
| Michael Keenan | Executive officer | May 2012 |
| Richard Treharne | Executive officer | May 2012 |
| Jack Blair | Executive officer | Apr 2011 |
| Lawrence Kluge | Executive officer | Apr 2011 |
| Michael Mainelli | Executive officer | Apr 2011 |
| Thomas Buford | Executive officer | Apr 2011 |
| Dennis Long | Executive officer | Dec 2009 |
| Larry Kluge | Executive officer | Dec 2009 |
| Michael Lewis | Executive officer | Dec 2009 |
| Noam Weissberg | Executive officer | Dec 2009 |
| Stephen Bradshaw | Executive officer | Apr 2009 |
| Troy Drewry | Executive officer | Apr 2009 |
| Amiram Steinberg | Director | May 2012 |
| Henry Klyce | Director | May 2012 |
| James Lackie | Director | May 2012 |
| William Mays, Jr. | Director | May 2012 |
| Jack Blair | Director | Apr 2011 |
| Michael Mainelli | Director | Apr 2011 |
| Charles Martin | Director | Dec 2009 |
| Stephen Bradshaw | Director | Apr 2009 |